Lymphocyte homing receptor (CD44) expression is associated with poor prognosis in gastrointestinal lymphoma.

por Joensuu, H., Ristamäki, R., Klemi, P. J., Jalkanen, S.
Publicado 1993

EGFR gene copy number assessment from areas with highest EGFR expression predicts response to anti-EGFR therapy in colorectal cancer

por Ålgars, A, Lintunen, M, Carpén, O, Ristamäki, R, Sundström, J
Publicado 2011

Reply: EGFR alterations and response to anti-EGFR therapy: is it a matter of gene amplification or gene copy number gain?

por Ålgars, A, Lintunen, M, Carpén, O, Ristamäki, R, Sundström, J
Publicado 2012

The adhesion molecule CD44v6 is associated with a high risk for local recurrence in adult soft tissue sarcomas

por Maula, S, Huuhtanen, R L, Blomqvist, C P, Wiklund, T A, Laurila, P, Ristamäki, R
Publicado 2001

Quality of life with biweekly docetaxel and capecitabine in advanced gastro-oesophageal cancer

por Korkeila, E. A., Salminen, T., Kallio, R., Mikkola, M., Auvinen, P., Pyrhönen, S., Ristamäki, R.
Publicado 2017

Impact of deep learning-determined smoking status on mortality of cancer patients: never too late to quit

por Karlsson, A., Ellonen, A., Irjala, H., Väliaho, V., Mattila, K., Nissi, L., Kytö, E., Kurki, S., Ristamäki, R., Vihinen, P., Laitinen, T., Ålgars, A., Jyrkkiö, S., Minn, H., Heervä, E.
Publicado 2021

Centralized repeated resectability assessment of patients with colorectal liver metastases during first-line treatment: prospective study

por Isoniemi, H, Uutela, A, Nordin, A, Lantto, E, Kellokumpu, I, Ovissi, A, Kosunen, J, Kallio, R, Soveri, L M, Salminen, T, Ålgars, A, Lamminmäki, A, Halonen, P, Ristamäki, R, Räsänen, J, Karjula, H, Vaalavuo, Y, Lavonius, M, Osterlund, P
Publicado 2021

Treatment response of colorectal cancer liver metastases to neoadjuvant or conversion therapy: a prospective multicentre follow-up study using MRI, diffusion-weighted imaging and (...

por Uutela, A., Ovissi, A., Hakkarainen, A., Ristimäki, A., Lundbom, N., Kallio, R., Soveri, L.M., Salminen, T., Ålgars, A., Halonen, P., Ristamäki, R., Nordin, A., Blanco Sequeiros, R., Rinta-Kiikka, I., Lantto, E., Virtanen, J., Pääkkö, E., Liukkonen, E., Saunavaara, J., Ryymin, P., Lammentausta, E., Osterlund, P., Isoniemi, H.
Publicado 2021

Continuation of fluoropyrimidine treatment with S-1 after cardiotoxicity on capecitabine- or 5-fluorouracil-based therapy in patients with solid tumours: a multicentre retrospectiv...

por Osterlund, P., Kinos, S., Pfeiffer, P., Salminen, T., Kwakman, J.J.M., Frödin, J.-E., Shah, C.H., Sorbye, H., Ristamäki, R., Halonen, P., Soveri, L.M., Heervä, E., Ålgars, A., Bärlund, M., Hagman, H., McDermott, R., O’Reilly, M., Röckert, R., Liposits, G., Kallio, R., Flygare, P., Teske, A.J., van Werkhoven, E., Punt, C.J.A., Glimelius, B.
Publicado 2022